Irish Regulator Invites Feedback On Strategic Plan For 2021-2025
Period Will Likely See Uncertainty And Changes In Regulatory Environment
Executive Summary
Ireland’s drug and medical device regulator is seeking stakeholder views on what its priorities should be over the next five years, given the uncertainties of Brexit and impending regulatory changes.
You may also be interested in...
Irish Regulator Pilots New Forum To Include Patient Input In Decisions
The Health Products Regulatory Authority has set up a new forum to get a deeper understanding of patient perspectives and experiences in relation to the regulation of drugs and medical devices.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.